Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.15 HKD | -4.59% | -1.37% | -9.13% |
Mar. 26 | Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 12 | Mega Genomics Stockholders to Vote March 1 on Continuing Transactions | MT |
Sales 2021 | 237M 32.87M 257M | Sales 2022 | 146M 20.2M 158M | Capitalization | 2.75B 381M 2.97B |
---|---|---|---|---|---|
Net income 2021 | 79M 10.95M 85.46M | Net income 2022 | -17M -2.36M -18.39M | EV / Sales 2021 * | - |
Net cash position 2021 | 451M 62.52M 488M | Net cash position 2022 | 398M 55.1M 430M | EV / Sales 2022 | 16.1 x |
P/E ratio 2021 * |
-
| P/E ratio 2022 |
-128
x | Employees | 229 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.86% |
1 day | -2.40% | ||
1 week | -1.37% | ||
Current month | -0.85% | ||
1 month | +4.00% | ||
3 months | -17.89% | ||
6 months | +14.15% | ||
Current year | -9.13% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Jiang
CEO | Chief Executive Officer | 44 | - |
Xiang Yi
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Xia An
COO | Chief Operating Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Rong Yu
FOU | Founder | 52 | 21-04-21 |
Mei Ling Guo
BRD | Director/Board Member | 54 | 21-08-05 |
Lin Lin
CHM | Chairman | 48 | 21-04-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 9.15 | -4.59% | 25 200 |
24-05-14 | 9.59 | +0.21% | 120,600 |
24-05-13 | 9.57 | +0.74% | 121,000 |
24-05-10 | 9.5 | +0.11% | 122,400 |
24-05-09 | 9.49 | 0.00% | 121,200 |
Delayed Quote Hong Kong S.E., May 15, 2024 at 11:54 pm EDT
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.13% | 291M | |
-15.96% | 8.79B | |
+67.50% | 4.19B | |
-4.03% | 2.48B | |
-42.54% | 2.29B | |
-6.49% | 1.97B | |
-20.45% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- 6667 Stock